» Articles » PMID: 32117715

Comparison of Survival and Risk Factors of Differentiated Thyroid Cancer in the Geriatric Population

Overview
Journal Front Oncol
Specialty Oncology
Date 2020 Mar 3
PMID 32117715
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence rate of differentiated thyroid cancer (DTC), the most common type of thyroid cancer, has increased in the past two decades. The present study analyzed the clinical and pathological characteristics of DTC, and discussed the risk factors for survival in elderly age-risk DTC patients. Elderly patients who were diagnosed with DTC, and subsequently underwent surgery for DTC, were identified from the SEER database (1988-2008). Based on histology, these patients were divided into C-PTC, FV-PTC, and FTC. The clinical characteristics, pathological features, and treatments undertaken were compared among these patients. Cox proportional hazards analysis was performed to evaluate the risk factors to disease-specific survival (DSS). In elderly DTC patients, FV-PTC shows intermediate tumor features compared to C-PTC and FTC, but presented a better outcome. Being male, African-American, tumors sized bigger than 4 cm, extrathyroidal extension, lymph node metastasis, and distant metastasis, were all strong risk factors for DSS in elderly DTC patients (all < 0.05). No difference was found between lobectomy and total thyroidectomy with respect to DSS, and radiation therapy conferred no apparent advantage with respect to DSS (both > 0.05). Patients with FV-PTC needed more specific histology cataloging and risk assessment, suggesting conservative therapy. Risk stratification should be paid attention to, and treatment should be individualized for elderly patients.

Citing Articles

KI-67 as a predictive indicator of papillary thyroid cancer in Iraqi patients.

Al-Timimi N, Baraaj A Probl Endokrinol (Mosk). 2025; 70(6):62-66.

PMID: 39868448 PMC: 11775681. DOI: 10.14341/probl13410.


The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review.

Muntean C, Solomon A, Cipaian R, Vonica R, Butuca A, Gaborean V J Clin Med. 2025; 14(2.

PMID: 39860342 PMC: 11765571. DOI: 10.3390/jcm14020338.


A prediction model based on random survival forest analysis of the overall survival of elderly female papillary thyroid carcinoma patients: a SEER-based study.

Lun Y, Yuan H, Ma P, Chen J, Lu P, Wang W Endocrine. 2024; 85(3):1252-1260.

PMID: 38558373 DOI: 10.1007/s12020-024-03797-1.


Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer.

White E, Abbott B, Schembri G, Glover A, Clifton-Bligh R, Gild M Front Endocrinol (Lausanne). 2023; 14:1160249.

PMID: 37766695 PMC: 10520546. DOI: 10.3389/fendo.2023.1160249.


Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis.

Zhao H, Liu C, Cao Y, Zhang L, Zhao Y, Liu Y Front Oncol. 2023; 12:990154.

PMID: 36591452 PMC: 9798085. DOI: 10.3389/fonc.2022.990154.


References
1.
Aschebrook-Kilfoy B, Ward M, Sabra M, Devesa S . Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid. 2010; 21(2):125-34. PMC: 3025182. DOI: 10.1089/thy.2010.0021. View

2.
Widder S, Guggisberg K, Khalil M, Pasieka J . A pathologic re-review of follicular thyroid neoplasms: the impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma. Surgery. 2008; 144(1):80-5. DOI: 10.1016/j.surg.2007.11.014. View

3.
Kinj R, Chand M, Gal J, Gautier M, Lam Cham Kee D, Hannoun-Levi J . Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly. Radiat Oncol. 2019; 14(1):234. PMC: 6925849. DOI: 10.1186/s13014-019-1448-0. View

4.
Passler C, Prager G, Scheuba C, Niederle B, Kaserer K, Zettinig G . Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg. 2003; 138(12):1362-6. DOI: 10.1001/archsurg.138.12.1362. View

5.
Kim S, Myong J, Suh H, Lee K, Youn Y . Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer. PLoS One. 2015; 10(6):e0130848. PMC: 4477980. DOI: 10.1371/journal.pone.0130848. View